Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 2
1970 5
1971 2
1972 2
1973 2
1974 3
1976 1
1977 1
1978 2
1979 2
1980 2
1981 10
1982 9
1983 6
1984 1
1985 3
1986 2
1987 2
1988 3
1989 4
1990 1
1991 1
1992 6
1993 1
1994 4
1995 1
1996 1
1997 2
1998 2
1999 4
2000 1
2001 1
2002 3
2003 2
2005 6
2006 2
2007 5
2008 10
2009 5
2010 2
2011 2
2012 2
2013 1
2015 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

129 results

Results by year

Filters applied: . Clear all
Page 1
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.
Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, Darius H, Lewis BS, Ophuis TO, Jukema JW, De Ferrari GM, Ruzyllo W, De Lucca P, Im K, Bohula EA, Reist C, Wiviott SD, Tershakovec AM, Musliner TA, Braunwald E, Califf RM; IMPROVE-IT Investigators. Cannon CP, et al. N Engl J Med. 2015 Jun 18;372(25):2387-97. doi: 10.1056/NEJMoa1410489. Epub 2015 Jun 3. N Engl J Med. 2015. PMID: 26039521 Free article. Clinical Trial.
Endothelin receptor antagonists.
Clozel M, Maresta A, Humbert M. Clozel M, et al. Among authors: maresta a. Handb Exp Pharmacol. 2013;218:199-227. doi: 10.1007/978-3-642-38664-0_9. Handb Exp Pharmacol. 2013. PMID: 24092342 Review.
A randomized double-blind comparison of biventricular versus left ventricular stimulation for cardiac resynchronization therapy: the Biventricular versus Left Univentricular Pacing with ICD Back-up in Heart Failure Patients (B-LEFT HF) trial.
Boriani G, Kranig W, Donal E, Calo L, Casella M, Delarche N, Lozano IF, Ansalone G, Biffi M, Boulogne E, Leclercq C; B-LEFT HF study group. Boriani G, et al. Am Heart J. 2010 Jun;159(6):1052-1058.e1. doi: 10.1016/j.ahj.2010.03.008. Am Heart J. 2010. PMID: 20569719 Clinical Trial.
Starc II, a multicenter randomized placebo-controlled double-blind clinical trial of trapidil for 1-year clinical events and angiographic restenosis reduction after coronary angioplasty and stenting.
Maresta A, Balducelli M, Latini R, Bernardi G, Moccetti T, Sosa C, Barlera S, Varani E, Ribeiro da Silva EE, Monici Preti A, Maggioni AP; STARC II Investigators. Maresta A, et al. Catheter Cardiovasc Interv. 2005 Mar;64(3):375-82. doi: 10.1002/ccd.20290. Catheter Cardiovasc Interv. 2005. PMID: 15736248 Clinical Trial.
Trapidil (triazolopyrimidine), a platelet-derived growth factor antagonist, reduces restenosis after percutaneous transluminal coronary angioplasty. Results of the randomized, double-blind STARC study. Studio Trapidil versus Aspirin nella Restenosi Coronarica.
Maresta A, Balducelli M, Cantini L, Casari A, Chioin R, Fabbri M, Fontanelli A, Monici Preti PA, Repetto S, De Servi S, et al. Maresta A, et al. Circulation. 1994 Dec;90(6):2710-5. doi: 10.1161/01.cir.90.6.2710. Circulation. 1994. PMID: 7994812 Clinical Trial.
Are drug-eluting stents superior to bare-metal stents in patients with unprotected non-bifurcational left main disease? Insights from a multicentre registry.
Tamburino C, Di Salvo ME, Capodanno D, Marzocchi A, Sheiban I, Margheri M, Maresta A, Barlocco F, Sangiorgi G, Piovaccari G, Bartorelli A, Briguori C, Ardissino D, Di Pede F, Ramondo A, Inglese L, Petronio AS, Bolognese L, Benassi A, Palmieri C, Patti A, De Servi S. Tamburino C, et al. Among authors: maresta a. Eur Heart J. 2009 May;30(10):1171-9. doi: 10.1093/eurheartj/ehp052. Epub 2009 Mar 10. Eur Heart J. 2009. PMID: 19276194
129 results